EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Quality-Adjusted Life-Years Outcome 1 Year After Surgery by Robotics-Assisted Sacral Hystero-Colpopexy Versus Vaginal Mesh for Pelvic Organ Prolapse Repair

Georgios Poutakidis, Kirk Geale, Edward Morcos iD

International Urogynecology Journal · 2026

DOI: 10.1007/s00192-025-06242-7 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Urogynecology Journal, 2026. Verfasst von Georgios Poutakidis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Division of Obstetrics and Gynecology, Karolinska Institutet Danderyd Hospital, 176 77, Stockholm, Sweden. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Robotic Surgical Procedures, Quality-Adjusted Life Years, Surgical Mesh. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Hypothesis The aim of this study was to compare the quality-adjusted life-years (QALYs) attained 1 year after robotics-assisted sacral hystero-colpopexy (RASC) versus Uphold™ vaginal mesh surgery for pelvic organ prolapse repair.

Methods

This was a secondary analysis of a previously published cohort study. A total of 65 patients who underwent RASC and 71 who underwent the Uphold™ procedure completed the 15-dimensional (15D) and the EuroQol five-dimensional three-level (EQ-5D-3L) instruments measuring health-related quality of life (HR-QoL). All patients had symptomatic and anatomical apical prolapse (POP-Q C ≥ stage II) with or without other vaginal wall defects. Changes in HR-QoL instruments were calculated and compared with minimal important change (MIC) thresholds and QALYs gained were estimated for each intervention.

Results

The 15D and EQ-5D-3L mean index scores were improved from preoperatively to 1 year after RASC ([0.88 ± 0.10 to 0.90 ± 0.01] and [0.85 ± 0.1 to 0.90 ± 0.1]) and after Uphold™= ([0.87 ± 0.1 to 0.89 ± 0.1] and [0.86 ± 0.1 to 0.93 ± 0.1], p 0.024 to p < 0.001) with no significant difference between cohorts. Prolapse-related 15D profile index measures, including discomfort, sexual activity, and distress were significantly improved after RASC ( p = 0.039 to < 0.001), whereas excretion, discomfort, and sexual activity were significantly improved after the Uphold™ ( p = 0.009 to < 0.001). The improvement in 15D scores from baseline to 1-year follow-up of + 0.026 for RASC and + 0.025 for Uphold™ exceeded the MIC, indicating meaningful improvements in patient quality of life. The overall 1-year QALY gain was estimated to be 0.90 ± 0.1 in the RASC and 0.88 ± 0.1 in the Uphold™ cohorts ( p < 0.001), with no significant difference between the two interventions ( p = 0.514).

Conclusions

The RASC and Uphold™ are both meaningful surgical treatments for prolapse, with significant improvement in the HR-QoL and the 1-year QALY gain and with no significant difference between the two surgeries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelvic Organ ProlapseRobotic Surgical ProceduresQuality-Adjusted Life YearsSurgical MeshGynecologic Surgical ProceduresHumansFemaleMiddle AgedAgedTreatment OutcomeQuality of LifeVaginaSacrum

Stichwörter der Autor:innen

15DApical prolapse surgeryEQ-5D-3LHR-QoLQALYRobotics-assisted sacral hystero-colpopexyUphold™ vaginal mesh

Autor:innen und Institutionen

  • Department of Clinical Sciences, Division of Obstetrics and Gynecology, Karolinska Institutet Danderyd Hospital, 176 77, Stockholm, Sweden.
  • Department of Obstetrics and Gynecology, Danderyd University Hospital, 182 88, Danderyd, Stockholm, Sweden.
  • Quantify Research, 112 21, Stockholm, Sweden.
  • Department of Clinical Sciences, Division of Obstetrics and Gynecology, Karolinska Institutet Danderyd Hospital, 176 77, Stockholm, Sweden. edward.morcos@regionstockholm.se.
  • Department of Obstetrics and Gynecology, Danderyd University Hospital, 182 88, Danderyd, Stockholm, Sweden. edward.morcos@regionstockholm.se.

ORCID-Profile: Edward Morcos

Förderung

  • Karolinska Institute

Zitieren

APA

Poutakidis, G., Geale, K., & Morcos, E. (2026). Quality-Adjusted Life-Years Outcome 1 Year After Surgery by Robotics-Assisted Sacral Hystero-Colpopexy Versus Vaginal Mesh for Pelvic Organ Prolapse Repair. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06242-7

Vancouver

Poutakidis G, Geale K, Morcos E. Quality-Adjusted Life-Years Outcome 1 Year After Surgery by Robotics-Assisted Sacral Hystero-Colpopexy Versus Vaginal Mesh for Pelvic Organ Prolapse Repair. International Urogynecology Journal. 2026. doi:10.1007/s00192-025-06242-7

BibTeX
@article{Poutakidis2026,
  author = {Poutakidis, Georgios and Geale, Kirk and Morcos, Edward},
  title = {Quality-Adjusted Life-Years Outcome 1 Year After Surgery by Robotics-Assisted Sacral Hystero-Colpopexy Versus Vaginal Mesh for Pelvic Organ Prolapse Repair},
  journal = {International Urogynecology Journal},
  year = {2026},
  doi = {10.1007/s00192-025-06242-7}
}
Kostenlos starten →